US OptionsDetailed Quotes
TMDX240920C190000
- 3.20
- -0.19-5.60%
15min DelayClose Aug 23 16:00 ET
3.20High3.20Low
3.20Open3.39Pre Close10 Volume138 Open Interest190.00Strike Price3.20KTurnover43.58%IV9.99%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier27DDays to Expiry3.20Extrinsic Value100Contract SizeAmericanOptions Type0.2834Delta0.0163Gamma50.92Leverage Ratio-0.1380Theta0.0341Rho14.43Eff Leverage0.1614Vega
TransMedics Stock Discussion
Sign in to post a comment
Owning stocks isn't enough -- you must understand what these companies do. If you can't summarize their business in one sentence, you might not truly know them.
Here are the one-liners for each stock in my portfolio 🧐
1. $CrowdStrike (CRWD.US)$ | Crowdstrike
• Their Falcon platform uses artificial AI and cloud technology to detect and respond to cyber threats by offering endpoint security, threat intelligence, and cyberattack response services.
2. $Snowflake (SNOW.US)$ | Snowflake
• A cloud-...
Here are the one-liners for each stock in my portfolio 🧐
1. $CrowdStrike (CRWD.US)$ | Crowdstrike
• Their Falcon platform uses artificial AI and cloud technology to detect and respond to cyber threats by offering endpoint security, threat intelligence, and cyberattack response services.
2. $Snowflake (SNOW.US)$ | Snowflake
• A cloud-...
87
4
TransMedics Group's trend of growing ROCE and increasing capital employed suggests profitable reinvestment opportunities, potentially leading to a multi-bagger performance. The stock's solid return to shareholders over the last three years indicates investor recognition of these changes.
1
$Advanced Micro Devices (AMD.US)$ was obvious to buy at $100 and many waited
$Celsius Holdings (CELH.US)$ at $48 (this year) was the easiest money and people waited.
$Palantir (PLTR.US)$ at $14 was extremely undervalued and many waited
$Meta Platforms (META.US)$ was obvious to buy at $200 and everyone waited
$CrowdStrike (CRWD.US)$ was a clear buy at $150 and people waited
$TransMedics (TMDX.US)$ at $38 with a market cap of $1 Billion was a steal and nobody wanted to buy it.
Focus on the essentials: align...
$Celsius Holdings (CELH.US)$ at $48 (this year) was the easiest money and people waited.
$Palantir (PLTR.US)$ at $14 was extremely undervalued and many waited
$Meta Platforms (META.US)$ was obvious to buy at $200 and everyone waited
$CrowdStrike (CRWD.US)$ was a clear buy at $150 and people waited
$TransMedics (TMDX.US)$ at $38 with a market cap of $1 Billion was a steal and nobody wanted to buy it.
Focus on the essentials: align...
9
3
$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
7
Insider selling over the past year, particularly in recent months, may indicate insiders believe shares are overpriced. Despite some insider buying, the long-term outlook lacks positivity. Insider ownership shows alignment with shareholders, but past sales warrant caution.
TransMedics Group's significant top-line growth is undermined by its negative EBIT, liabilities outstripping cash and near-term receivables by $75m, and increased cash burn over the past year, constituting substantial risk.
Oppenheimer analysts hail TransMedics' recent quarter as 'blockbuster', emphasizing its long-term strategy to overcome short term challenges. The game-changing potential of the Organ Care System technology to reshape organ preservation and transport is also highlighted.
1
wheres everyone
and why did this run up all on its own
and why did this run up all on its own
Positive interpretation of recent purchases at TransMedics Group amidst potential concerns over last year's sales. Insiders' stakes display alignment between management and smaller shareholders.
No comment yet
BH_6730 : Fantastic
眼观六路的沃勒 : Like
Master Corgi : Damn you miss out PANW
Dramericanjesus : Being able to read a financial statement is far more valuable.